-
1دورية أكاديمية
المؤلفون: Pantano F., Russano M., Berruti A., Mansueto G., Migliorino M. R., Adamo V., Aprile G., Gelibter A., Ficorella C., Falcone A., Russo A., Aieta M., Maio M., Martelli O., Barni S., Napolitano A., Roca E., Quadrini S., Iacono D., Calvetti L., Occhipinti M. A., Cortellini A., Vasile E., Passiglia F., Imperatori M., Calabro L., Di Giacomo A. M., Petrelli F., Pasquini G., Franchina T., Venditti O., Intagliata S., Galvano A., Fioroni I., Vincenzi B., Tonini G., Santini D.
المساهمون: Pantano F., Russano M., Berruti A., Mansueto G., Migliorino M.R., Adamo V., Aprile G., Gelibter A., Ficorella C., Falcone A., Russo A., Aieta M., Maio M., Martelli O., Barni S., Napolitano A., Roca E., Quadrini S., Iacono D., Calvetti L., Occhipinti M.A., Cortellini A., Vasile E., Passiglia F., Imperatori M., Calabro L., Di Giacomo A.M., Petrelli F., Pasquini G., Franchina T., Venditti O., Intagliata S., Galvano A., Fioroni I., Vincenzi B., Tonini G., Santini D.
مصطلحات موضوعية: Immunotherapy, malignant pleural effusion, Nivolumab, non-Small-Cell Lung Cancer
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32011207; info:eu-repo/semantics/altIdentifier/wos/WOS:000513082900001; volume:20; issue:3; firstpage:319; lastpage:326; numberofpages:8; journal:EXPERT OPINION ON BIOLOGICAL THERAPY; http://hdl.handle.net/10447/407127Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079466504
-
2دورية أكاديمية
المؤلفون: Tartarone A, Roviello G, Lerose R, Roudi R, Aieta M, Zoppoli P.
المساهمون: Tartarone, A, Roviello, G, Lerose, R, Roudi, R, Aieta, M, Zoppoli, P.
مصطلحات موضوعية: atezolizumab, avelumab, checkpoint inhibitor, immunotherapy, meta-analysi, nivolumab, non-small-cell lung cancer, pembrolizumab, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Human, Lung Neoplasm, Programmed Cell Death 1 Receptor, Progression-Free Survival, Survival Analysis
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000478996300011; volume:15; issue:20; firstpage:2423; lastpage:2433; numberofpages:11; journal:FUTURE ONCOLOGY; https://hdl.handle.net/11588/898547Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070081200
-
3
المؤلفون: Francesco Passiglia, Michele Aieta, Marco Imperatori, Giovanni Mansueto, Marco Russano, Alfredo Berruti, Giulia Pasquini, Daniele Santini, Elisa Roca, Tindara Franchina, Lorenzo Calvetti, Antonio Galvano, Anna Maria Di Giacomo, Iacopo Fioroni, Giuseppe Aprile, Daniela Iacono, Alessio Cortellini, Sandro Barni, Olga Martelli, Luana Calabrò, Michele Maio, Alain Gelibter, Maria Rita Migliorino, Bruno Vincenzi, Alessandro Russo, Corrado Ficorella, Olga Venditti, Silvia Quadrini, Salvatore Intagliata, Enrico Vasile, Giuseppe Tonini, Fausto Petrelli, Vincenzo Adamo, Alfredo Falcone, Mario Occhipinti, Antonio Russo, Andrea Napolitano, Francesco Pantano
المساهمون: Pantano F., Russano M., Berruti A., Mansueto G., Migliorino M.R., Adamo V., Aprile G., Gelibter A., Ficorella C., Falcone A., Russo A., Aieta M., Maio M., Martelli O., Barni S., Napolitano A., Roca E., Quadrini S., Iacono D., Calvetti L., Occhipinti M.A., Cortellini A., Vasile E., Passiglia F., Imperatori M., Calabro L., Di Giacomo A.M., Petrelli F., Pasquini G., Franchina T., Venditti O., Intagliata S., Galvano A., Fioroni I., Vincenzi B., Tonini G., Santini D.
مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Clinical Biochemistry, Kaplan-Meier Estimate, Disease-Free Survival, Drug Administration Schedule, NO, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Drug Discovery, medicine, Malignant pleural effusion, Humans, immunotherapy, malignant pleural effusion, nivolumab, non-small-cell lung cancer, In patient, Lung cancer, Immune Checkpoint Inhibitors, Retrospective Studies, Pharmacology, business.industry, Brain Neoplasms, Liver Neoplasms, Immunotherapy, medicine.disease, Prognosis, Pleural Effusion, Malignant, respiratory tract diseases, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Female, sense organs, Non small cell, Nivolumab, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b5be2e8e2810f947ef83391c385b04Test
http://hdl.handle.net/11573/1484803Test